RAREBASE
Rarebase is as networking Portal links people throughout the world with an interest in rare and paediatric diseases.
RAREBASE
Industry:
Health Care Medical
Founded:
2014-10-25
Address:
Wilmslow, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.rarebase.co.uk
Total Employee:
1+
Status:
Active
Contact:
0345 363 3632
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Universal Analytics AJAX Libraries API ASP.NET
Official Site Inspections
http://www.rarebase.co.uk
- Host name: ntc3-p1rea.reaaos.com
- IP address: 5.10.29.193
- Location: Leigh-on-Sea United Kingdom
- Latitude: 51.5554
- Longitude: 0.6466
- Timezone: Europe/London
- Postal: SS9
More informations about "Rarebase"
Rarebase - Crunchbase Company Profile & Funding
Rarebase is a biotech and research and development firm. It offers to construct a modality-agnostic research roadmap to bring medicines to the clinic as well as a liberated collection of tools and resources to speed up therapeutic discovery, …See details»
Rarebase - Crunchbase Company Profile & Funding
Oct 4, 2020 · Where is Rarebase's headquarters? Rarebase is located in Palo Alto, California, United States. Who are Rarebase's competitors? Alternatives and possible competitors to Rarebase may include Chimeron Bio, Lysosomal …See details»
Rarebase launches a neuroscience drug discovery …
Sep 14, 2021 · Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function’s 15 patient organization collaborators represent genes that cause epilepsy, autism, …See details»
Rarebase launches a neuroscience drug discovery …
PALO ALTO, Calif., Sept. 14, 2021 /PRNewswire/ -- Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function's 15 patient...See details»
Rarebase is on the hunt for therapeutic opportunities
Oct 31, 2022 · The big-data revolution in biomedical research has enabled Rarebase to address the gap in rare disease drug discovery in a novel way: by studying thousands of rare genetic diseases within a single research platform, …See details»
Rarebase Launches a Neuroscience Drug Discovery …
Rarebase, a public benefit biotechnology company, launched its tech-enabled drug discovery platform called Function. Function combines two unique data sets: large scale drug screens and genetic screens performed in neurons.See details»
Rarebase - VentureRadar
Rarebase is a public benefit corporation pioneering a new approach to biotech. We currently partner with over 15 patient organizations and families on translational therapeutic discovery …See details»
Rarebase - Leadership Team - The Org
The Leadership Team at Rarebase is responsible for steering the company's strategic vision and operational excellence.See details»
Transcripta Bio
Our team sat down with Dr. Iorns, whose scientific expertise includes high-throughput screening approaches, to discuss the realities of discovering therapies for rare diseases — and how …See details»
Founder Spotlight #17: Onno Faber @ Rarebase | by …
Apr 27, 2021 · Onno Faber is Co-Founder & CEO @ Rarebase — identifying & developing infrastructure across rare disorders to accelerate therapeutic development. After spending a career in tech, Onno switched his...See details»
Rarebase launches a neuroscience drug discovery …
Sep 15, 2021 · PALO ALTO, Calif., Sept. 14, 2021 /PRNewswire/ -- Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function's 15 patient organization collaborators …See details»
Rarebase Announces Promotion of Chris Moxham to President
Jul 13, 2023 · Rarebase is a true platform drug development biotech that is revolutionizing the process of discovering and developing medicines at unprecedented speed, scale, and capital …See details»
Rarebase launches a neuroscience drug discovery platform
PALO ALTO, Calif., Sept. 14, 2021 /PRNewswire/ -- Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function's 15 …See details»
Rarebase Launches Collaborative Platform to Find New Therapies
Dec 30, 2021 · In total, 15 rare disease patient organizations have partnered with Rarebase in the Function platform, including the Charlotte and Gwenyth Gray Foundation, which advocates …See details»
Rarebase Is on the Hunt for Therapeutic Opportunities - Yahoo …
Nov 7, 2022 · At a meetup for families affected by rare diseases, Jainu met Onno Faber and Omid Karkouti, co-founders of Rarebase, a precision medicine company dedicated to discovering …See details»
HNF collaborates with Rarebase on a Drug Discovery Platform to …
Oct 12, 2021 · Rarebase is a public benefit biotech company focused on accelerating therapy development for rare diseases with its tech-enabled drug discovery platform called "Function". …See details»
Rarebase Is on the Hunt for Therapeutic Opportunities
Nov 8, 2022 · The big-data revolution in biomedical research has enabled Rarebase to address the gap in rare disease drug discovery in a novel way: by studying thousands of rare genetic …See details»
Rarebase Names Chris Moxham as Chief Executive Officer
Oct 4, 2023 · Rarebase is a true platform drug development biotech that is revolutionizing the process of discovering and developing medicines at unprecedented speed, scale, and capital …See details»
Transcripta Bio (Rarebase) Uses AI for Rare-Disease Drugs
Apr 24, 2024 · Transcripta Bio’s AI software analyzes rare diseases to see if existing pharmaceuticals can help. At Transcripta Bio, automated robotics for high-throughput …See details»
Onno Faber - Rarebase - LinkedIn
Onno Faber is a seasoned entrepreneur, most recently served as the CEO and Co-founder of… · Experience: Rarebase · Education: Technische Universiteit Delft · Location: Palo Alto · 500+...See details»